Duchenne Nurse Educator
San Franciscohybrid$136K – $170K
Posted yesterday · via Workday
About this role
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We’re looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients. What Sarepta Offers At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives.…
What we'd score you on
reqspace match rubricFive dimensions, recruiter-grade. Upload your resume and we'll generate a written explanation of where you fit and where the gaps are.
1
Skills match
For this role: teams
2
Level fit
We check your title trajectory against the seniority signal of the role.
3
Domain experience
Your work in the role's domain matters more than your years total. We weight recent and direct experience.
4
Recency
A skill you used last quarter weighs more than one from five years ago. We grade on recency, not lifetime.
5
Location fit
This role is based in San Francisco. We weight your proximity and willingness to relocate.
Score yourself on this role.
Free · no card · written explanation included
Skills in this role
Pulled from the job description. These are the keywords we'll weight when scoring your fit.
teams
More at Sarepta Therapeutics
- View →Senior Manager, Corporate Quality – R&D AuditsBedford, MA
- View →Director, Commercial Learning and DevelopmentCambridge, MA
- View →Senior Clinical Operations LeadCambridge, MA
- View →Senior Director, Corporate Quality – PVBedford, MA
- View →Associate Director, Commercial Analytics and Business OperationsCambridge, MA
- View →Senior Manager, Forecasting & AnalyticsCambridge, MA